Aspirin improves short and long term survival outcomes of patients with sepsis associated encephalopathy.

Sepsis-associated encephalopathy (SAE) is a common complication of sepsis, characterized by altered mental status and contributing to higher mortality. Aspirin, an antiplatelet agent with anti-inflammatory properties, may improve outcomes in patients with SAE. This study aims to evaluate the effect of aspirin on the prognosis of patients with SAE.